Lowering cysteine levels may boost fat burning and trigger brown fat production, offering a new approach to weight loss and ...

World Population Day 2025 reminds us that behind the 8 billion count are lives, challenges, and global trends demanding ...

Genomic psychiatry is reshaping how we treat bipolar disorder—using genes to predict lithium response and personalize mental ...

Discovery of CXCL12’s role in red blood cell development could revolutionize artificial blood production and help address ...

Analysis of hydroxychloroquine dosage in hospitalized COVID-19 patients shows low-dose benefits and high-dose risks.

An autonomous fabric electrochemical biosensor for efficient health monitoring - ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness, diagnosis, and research for thymidine kinase 2 deficiency (TK2d).

U.S. FDA grants Orphan Drug Designation to Adcentrx's ADRX-0405 STEAP1 ADC for the treatment of gastric cancer ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced t ...

A unified federal approach to health data sharing, developed in partnership with states, could accelerate progress in cancer prevention, care, and research LOS ANGELES, July 8, 2025 /PRNewswire/ -- ...

ChristianaCare and Children's Hospital of Philadelphia (CHOP) today announce a new strategic affiliation to expand access to world-class pediatric care in Delaware and surrounding communities. A Bold ...